CymitQuimica logo

CAS 2229711-68-4

:

ARV-471

Description:
ARV-471 is a novel investigational compound primarily being studied for its potential use in the treatment of breast cancer. It is classified as a selective estrogen receptor degrader (SERD), which means it is designed to bind to estrogen receptors and promote their degradation, thereby inhibiting estrogen-driven tumor growth. This mechanism is particularly relevant in hormone receptor-positive breast cancers, where estrogen plays a significant role in tumor proliferation. ARV-471 has shown promise in preclinical and clinical studies, demonstrating the ability to effectively reduce tumor size and improve patient outcomes. Its chemical structure features specific functional groups that enhance its binding affinity and selectivity for estrogen receptors. Additionally, ARV-471 is being evaluated for its safety profile and pharmacokinetics, which are crucial for determining its therapeutic potential. As research continues, ARV-471 may offer a new treatment option for patients with breast cancer, particularly those who have developed resistance to traditional endocrine therapies.
Formula:C45H49N5O4
Synonyms:
  • 2,6-Piperidinedione, 3-[1,3-dihydro-1-oxo-5-[4-[[1-[4-[(1R,2S)-1,2,3,4-tetrahydro-6-hydroxy-2-phenyl-1-naphthalenyl]phenyl]-4-piperidinyl]methyl]-1-piperazinyl]-2H-isoindol-2-yl]-, (3S)-
  • 2,6-PIPERIDINEDIONE, 3-[1,3-DIHYDRO-1-OXO-5-[4-[[1-[4-[(1R,2S)-1,2,3,4-TETRAHYDRO-6-HYDROXY-2-PHENYL
  • Vepdegestrant
  • ARV-471
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
  • Ref: IN-DA01V7C7

    1mg
    164.00€
    5mg
    513.00€
    10mg
    656.00€
    25mg
    To inquire
    50mg
    To inquire
    100mg
    To inquire
  • ARV-471

    CAS:
    ARV-471
    Purity:≥95%
    Molecular weight:723.9g/mol

    Ref: 54-BUP09613

    1g
    4,733.00€
    5mg
    612.00€
    10mg
    856.00€
    25mg
    1,173.00€
    50mg
    1,595.00€
    500mg
    3,574.00€
  • ARV-471

    CAS:
    <p>ARV-471 (Vepdegestrant) is a orally active Cereblon -based estrogen receptor (ER) PROTAC degrader. ARV-471 is developed for the research of breast cancer.</p>
    Formula:C45H49N5O4
    Purity:97.15% - >99.99%
    Color and Shape:Solid
    Molecular weight:723.9
  • ARV-471-d8

    CAS:
    Formula:C45H41D8N5O4
    Molecular weight:731.97

    Ref: 4Z-A-339003

    5mg
    To inquire
    10mg
    To inquire
    25mg
    To inquire
    50mg
    To inquire
    100mg
    To inquire
  • ARV-471

    CAS:
    Formula:C45H49N5O4
    Molecular weight:723.92

    Ref: 4Z-A-339001

    5mg
    To inquire
    10mg
    To inquire
    25mg
    To inquire
    50mg
    To inquire
    100mg
    To inquire
  • ARV-471-d5

    CAS:
    Formula:C45H44D5N5O4
    Molecular weight:728.95

    Ref: 4Z-A-339002

    5mg
    To inquire
    10mg
    To inquire
    25mg
    To inquire
    50mg
    To inquire
    100mg
    To inquire
  • ARV-471

    CAS:
    ARV-471 is an anticancer drug that acts as a Chinese hamster ovary (CHO) cell inhibitor. It is a potent and selective kinase inhibitor that has been shown to induce apoptosis in cancer cells. ARV-471 is a protein analog of nifedipine, which is a calcium channel blocker used to treat high blood pressure and angina. This drug works by inhibiting kinases, which are enzymes that regulate cellular growth and proliferation. ARV-471 has been demonstrated to be effective in treating various types of cancer, including breast cancer, by inhibiting the growth of tumor cells and inducing apoptosis. Its unique mechanism of action makes it a promising candidate for future cancer therapies.
    Formula:C45H49N5O4
    Purity:Min. 95%
    Molecular weight:723.9 g/mol

    Ref: 3D-EPD71168

    5mg
    668.00€
    10mg
    806.00€
    25mg
    1,036.00€
    50mg
    1,193.00€
    100mg
    1,518.00€